Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02360306 · ClinicalTrials.gov registry record · NA
The Analysis of the EBUS Scope as a Hybrid Bronchoscope
A NA study of Lymphadenopathy, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
- 1
- Study location
NCT02360306 is a NA study of Lymphadenopathy that has completed, run by Johns Hopkins University. The registered enrollment target is 62 participants, below the 69-participant average among 5 other Lymphadenopathy trials with a reported enrollment target (10% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02360306, a NA study of Lymphadenopathy, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
- 1
- Study location
Study Summary
Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is widely used in the diagnosis of mediastinal and hilar adenopathy as well as in staging in lung cancer patients. Many studies have confirmed the utility of EBUS-TBNA with high sensitivity, specificity, and accuracy for the diagnosis of mediastinal and hilar adenopathy. 1-3 Less well reported has been the use of the EBUS bronchoscope to perform other procedures such as transbronchial biopsy (TBBx), endobronchial biopsy (EBBx), bronchoalveolar lavage (BAL) and airway brushings. While not well reported in the medical literature, anecdotal evidence supports these practices. The investigators propose a methodological evaluation of the full spectrum of procedures that have been performed and that are possible using an EBUS bronchoscope.
Conditions Studied
Interventions
- PROCEDURE Endobronchial Ultrasound
Study Locations (1)
Maryland
- Johns Hopkins Hospital - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2013-01 |
| Est. Completion | 2014-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02360306
The ClinicalTrials.gov registry entry for NCT02360306 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 69-participant average among 5 other Lymphadenopathy trials with a reported enrollment target (10% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lymphadenopathy appearing as the primary indexed condition, and to 1 intervention - of which Endobronchial Ultrasound is the first listed.
NCT02360306 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT02360306 about?
NCT02360306 is a clinical study titled "The Analysis of the EBUS Scope as a Hybrid Bronchoscope". Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is widely used in the diagnosis of mediastinal and hilar adenopathy as well as in staging in lung cancer patients. Many studies have confirmed the utility of EBUS-TBNA with high sensitivity, specificity, and accuracy for th...
What is the current status of trial NCT02360306?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2013-01. Estimated completion is 2014-01.
What conditions does trial NCT02360306 study?
This clinical trial studies the following conditions: Lymphadenopathy.
What interventions are being tested in trial NCT02360306?
The interventions under investigation include: Endobronchial Ultrasound (PROCEDURE).
Who is sponsoring clinical trial NCT02360306?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02360306 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphadenopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Retroperitoneal Lymph Node Dissection in Treating Patients With Testicular Seminoma
ACTIVE NOT RECRUITING · NA
-
Prospective Trial of EUS-FNA Versus EUS-FNB Using a Novel Core Biopsy Needle
COMPLETED · NA
-
Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant
ACTIVE NOT RECRUITING · Phase 2
-
Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract
COMPLETED
-
Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.